TRENTON, N.J. (AP) — One of the hot new cancer immunotherapy drugs, Merck & Co.'s Keytruda, strongly benefited patients with melanoma, lung cancer and mesothelioma, according to three stud…
Search Results - stltoday.com, St. Louis Post-Dispatch: Business
Sun, 04/19/2015 - 11:56am
TRENTON, N.J. (AP) — One of the hot new cancer immunotherapy drugs, Merck & Co.'s Keytruda, strongly benefited patients with melanoma, lung cancer and mesothelioma, according to three stud…